
TRAIN Newsletter — June 2022

National Institutes of Health (NIH) Director Nomination

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870

Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006

Request for Information on Improving Americans’ Access to Gene Therapies

An Update from MI Health—July 2024

Medicare Drug Price Negotiation Program comment letter

Center for Public Health Newsletter: Summer 2022

Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
